Bingzhi Wang
Papers
1
Total Citations
3
H-Index
1
About
Dr. Bingzhi Wang is a pioneering urologic surgeon whose research centers on advancing minimally invasive surgical techniques for prostate cancer treatment, with a particular focus on robot-assisted radical prostatectomy (RARP). His major contribution lies in refining single-site multiport RARP (ssmpRARP) using the da Vinci Si® platform, a novel extraperitoneal approach designed to reduce surgical trauma while maintaining oncologic efficacy. In his landmark 2022 study, Wang conducted a rigorous propensity score matching comparative analysis, demonstrating that ssmpRARP offers comparable outcomes to conventional multiport RARP, with potential benefits in recovery and cosmesis. This work, which has garnered early citations, establishes a foundation for broader adoption of single-site robotic surgery. Dr. Wang’s research directly addresses the surgical community’s quest for less invasive yet effective prostate cancer treatments, positioning him as an emerging leader in urologic oncology and robotic surgery innovation.
Research Focus
Key Achievements
Top Papers
- 1